Weight reduction and maintenance with IQP-PV-101: a 12-week randomized controlled study with a 24-week open label period.

Objective: The safety and efficacy of IQP-PV-101, a proprietary extract of Phaseolus vulgaris, on weight management in two phases was evaluated here. The weight loss (WL) phase was conducted over 12 weeks and the weight maintenance (WM) phase took 24 weeks.

Methods: In the double-blind WL phase, subjects were randomized to receive either IQP-PV-101 or placebo.